{"SPADE_N_13819": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_13819", "Peptide Name": "As-CATH8 (A. sinensis cathelicidin 8; natural AMPs; Chinese alligator, crocodilian, reptiles, animals; BBN, UCLL1a)", "Source": "Chinese alligator,Alligator sinensis,  China, Asia", "Family": "Not found", "Gene": "Not found", "Sequence": "KRVNWAKVGRTALKLLPYIFG", "Sequence Length": 21, "UniProt Entry": "Ref", "Protein Existence": "Not found", "Biological Activity": ["Anti-Gram+", "Anti-Gram-"], "Target Organism": "Not found", "Hemolytic Activity": "Not found", "Cytotoxicity": "Not found", "Binding Target": "Not found", "Linear/Cyclic": "Not found", "N-terminal Modification": "Not found", "C-terminal Modification": "Not found", "Stereochemistry": "Not found", "Structure Description": "Not found", "Formula": "Not found", "Mass": 2430.93, "PI": 11.17, "Hydrophobicity": 0.06, "Half Life": "Not found", "Function": "Not found", "Literature": [{"Author": "Santana FL, Estrada K, Alford MA, Wu BC, Dostert M, Pedraz L, Akhoundsadegh N, Kalsi P, Haney EF, Straus SK, Corzo G, Hancock REW. 2022", "Reference": "Antibiotics (Basel). 2022 Nov 11;11(11):1603. doi: 10.3390/antibiotics11111603.MDPI", "Title": "Novel Alligator Cathelicidin As-CATH8 Demonstrates Anti-Infective Activity against Clinically Relevant and Crocodylian Bacterial Pathogens"}], "Frequent Amino Acids": "KLA", "Absent Amino Acids": "CDEHMOQSU", "Basic Residues": 5, "Acidic Residues": 0, "Hydrophobic Residues": 12, "Polar Residues": 12, "Positive Residues": 5, "Negative Residues": 0, "Net Charge": 5, "Comments": "Sequence analysis: APD analysis reveals this sequence is most similar (60%) toAs-CATH7L=V=G=R: 13%. GRAVY: -0.15; Mol Wt: 2693.147; Mol formula:  C122H201N36O31; mol ex Coeff:  7040.Activity: Active against E-faecium (MIC >64 uM), S. aureus (MIC 0.5 uM), K. pneumoniae (MIC 0.5 uM), A. baumannii (MIC 0.25 uM), P. aeruginosa (MIC 1 uM), E. cloacae (MIC 0.5 uM), E. coli (MIC 1 uM), S. Typhimurium (MIC 1 uM), and P. vulgaris (MIC 4 uM). Also inhibit biofilm formation.Organoid skin model: it eradicated S. aureus biofilms after 24 h treated at 200 ug. Animal model:mouse: it also showed an effect on skin infection.Structure: helical in SDS or DPC micelles.MOA: It depolarizes and permeabilizes membranes, which may lead to DNA binding (DNA retardation assay). Updated ref 5/2023", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_13928", "Similarity": 0.5833333333333334, "Sequence": "WRGALKLLFYAT"}, {"SPADE_ID": "SPADE_UN_13929", "Similarity": 0.5833333333333334, "Sequence": "WRGALKLLFYAT"}, {"SPADE_ID": "SPADE_N_13818", "Similarity": 0.5714285714285714, "Sequence": "KRVNWRKVGRNTALGASYVLSFLG"}]}}}